Future Virology

Scope & Guideline

Transforming Insights into Impactful Solutions

Introduction

Delve into the academic richness of Future Virology with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1746-0794
PublisherFUTURE MEDICINE LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2007 to 2024
AbbreviationFUTURE VIROL / Future Virol.
Frequency18 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressUNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB, ENGLAND

Aims and Scopes

Future Virology aims to advance the understanding of viral diseases through comprehensive research, innovative methodologies, and interdisciplinary approaches. The journal encompasses a diverse range of topics within virology, focusing on both fundamental research and applied science.
  1. Antiviral Research and Development:
    The journal emphasizes the development of novel antiviral agents, therapies, and treatment strategies for various viral infections, including emerging and re-emerging viruses.
  2. Viral Pathogenesis and Host Interaction:
    Investigation into the mechanisms of viral infection, replication, and pathogenesis, alongside the host's immune response and genetic factors influencing susceptibility and disease outcomes.
  3. Clinical Virology and Epidemiology:
    Research on the clinical aspects of viral infections, including epidemiological studies, diagnostics, treatment outcomes, and public health implications.
  4. Innovative Diagnostic Techniques:
    Development and assessment of new diagnostic tools and methodologies for the detection and monitoring of viral infections.
  5. Vaccine Development and Immunization Strategies:
    Exploration of vaccine efficacy, safety, and development strategies for various viral pathogens, with a focus on innovative approaches and technologies.
  6. Emerging Viral Threats and One Health Perspectives:
    Addressing the public health implications of emerging viruses, zoonotic diseases, and the interconnectedness of human, animal, and environmental health.
Future Virology is witnessing significant growth in several emerging themes, reflecting the evolving landscape of viral research and the urgent need for innovative solutions in virology.
  1. COVID-19 Research and Long-Term Effects:
    The ongoing research surrounding COVID-19, including long-term health impacts, vaccine efficacy, and therapeutic options, remains a dominant theme as the pandemic continues to evolve.
  2. Innovative Therapeutics and Drug Repurposing:
    There is an increased emphasis on the discovery and application of novel antiviral therapies, including drug repurposing strategies, particularly in response to the COVID-19 pandemic.
  3. Genomic and Molecular Epidemiology:
    Research focusing on the genomic characterization of viral pathogens and the epidemiological dynamics of viral spread is gaining traction, providing insights into transmission patterns and mutation rates.
  4. Viral Immunology and Host Interaction Studies:
    Emerging interest in understanding the complex interactions between viruses and host immune responses, including the role of host genetics in disease susceptibility.
  5. Nanotechnology and Advanced Delivery Systems:
    Exploration of nanotechnology applications in virology, particularly in drug delivery systems and vaccine development, is becoming increasingly relevant.
  6. Public Health and Policy Implications of Viral Diseases:
    Research addressing the broader implications of viral diseases on public health policy, vaccine distribution, and community health strategies is emerging as a critical area of focus.

Declining or Waning

While Future Virology continues to explore a wide array of topics, certain themes appear to be on the decline based on recent publication trends. These waning scopes may reflect shifts in research focus or advancements in understanding that render previous topics less prominent.
  1. Traditional Antiviral Agents:
    Research on older antiviral agents is becoming less frequent as newer therapies and innovative approaches gain traction. The focus is shifting towards developing novel compounds and therapeutic strategies.
  2. Viral Infections in Non-Human Hosts:
    Studies specifically targeting viral infections in animal models or non-human hosts have seen a decline, possibly as focus moves towards human-related health issues and zoonotic risks.
  3. Basic Virology Studies:
    There is a noticeable decrease in purely basic virology research that does not directly relate to clinical applications or emerging threats, as the journal aims to maintain a practical relevance.
  4. Viral Infections in Specific Populations:
    Research focusing solely on niche populations or specific demographics, such as rare infections in isolated communities, is less prevalent, indicating a broader focus on more generalizable findings.

Similar Journals

REVIEWS IN MEDICAL VIROLOGY

Advancing the Frontiers of Virology Research
Publisher: WILEYISSN: 1052-9276Frequency: 6 issues/year

REVIEWS IN MEDICAL VIROLOGY is a premier academic journal published by Wiley, dedicated to advancing the field of virology and infectious diseases. Established in 1991, this journal has gained a reputable standing, holding a Q1 ranking in both Infectious Diseases and Virology as of 2023, with impressive Scopus rankings placing it at #17 out of 344 in the realm of Medicine - Infectious Diseases, and #8 out of 80 in Immunology and Microbiology - Virology. This reflects its substantial impact factor and contribution to ongoing research and scholarship. While it is not an Open Access publication, REVIEWS IN MEDICAL VIROLOGY offers vital insights and comprehensive reviews that cater to a diverse audience including researchers, healthcare professionals, and students pursuing knowledge in medical virology. The journal serves as a vital resource for understanding the complexities of viral pathogens and the evolving landscape of antiviral therapeutics, making it an essential read for those poised at the forefront of infectious disease research.

JOURNAL OF VIROLOGICAL METHODS

Advancing virology through innovative methodologies.
Publisher: ELSEVIERISSN: 0166-0934Frequency: 16 issues/year

Journal of Virological Methods, published by Elsevier, is a prominent peer-reviewed journal dedicated to advancing the methodologies employed in virology research. Since its inception in 1980, this esteemed journal has become a vital resource for researchers, professionals, and students focused on the intricate study of viruses and viral-related diseases. With a current ISSN of 0166-0934 and an E-ISSN of 1879-0984, this journal strives to present innovative techniques and tools that enhance our understanding of virology. Designed for a global audience, it operates in a rigorous academic environment, as reflected by its 2023 Scopus ranking of #40 in the Virology category and its Q3 quartile placement. The journal is committed to fostering open dialogue and collaboration within the scientific community, ultimately contributing to the development of novel strategies and interventions against viral infections. By offering comprehensive insights into virological methodologies, the Journal of Virological Methods continuously serves as a cornerstone for those dedicated to exploring the complexities of viral research.

ARCHIVES OF VIROLOGY

Elevating the discourse on viral health impacts.
Publisher: SPRINGER WIENISSN: 0304-8608Frequency: 12 issues/year

Archives of Virology is a prestigious academic journal dedicated to the field of virology, published by Springer Wien. Established in 1975, this journal has been a crucial platform for disseminating innovative research findings and advancements in the understanding of viral diseases and their impact on human health. It holds a notable position in the academic landscape, with a 2023 impact factor placing it in Q2 within the field of Medicine (miscellaneous) and Q3 in Virology. Its Scopus ranking within the Virology category further underscores its relevance, with a notable percentile of 45th. Although it does not provide Open Access options, the journal's rigorous peer-review process ensures the highest quality of published work, making it an essential resource for researchers, professionals, and students aiming to stay updated in the rapidly evolving field of virology. For those committed to advancing their understanding of viruses and viral diseases, Archives of Virology is a vital scholarly resource.

Advances in Virology

Unleashing Innovation in Viral Science
Publisher: HINDAWI LTDISSN: 1687-8639Frequency: 1 issue/year

Advances in Virology, an esteemed journal published by HINDAWI LTD, serves as a pivotal platform for cutting-edge research in the field of virology and infectious diseases. With its ISSN 1687-8639 and E-ISSN 1687-8647, the journal has been a significant contributor to the scientific community since its initiation as an Open Access resource in 2009, allowing researchers from around the globe to access groundbreaking findings without barriers. Operating out of the United States and recognized for its commitment to high-quality research, the journal's relevance is underscored by its ranking in the Q3 category for Infectious Diseases and Q4 for Virology as of 2023. The time frame of publications spans from 2009 to 2024, reflecting a continuous commitment to exploring the evolving landscape of virology. This journal not only promotes the dissemination of novel insights and methodologies but also fosters collaboration and innovation within the scientific community, making it an invaluable resource for researchers, professionals, and students alike.

VIRUS GENES

Exploring the Genetic Blueprint of Viruses
Publisher: SPRINGERISSN: 0920-8569Frequency: 6 issues/year

VIRUS GENES is an esteemed journal published by Springer, dedicated to advancing our understanding of virology and its related fields, including genetics, molecular biology, and immunology. With a publication history that spans from 1987 to 2024, this journal provides researchers and professionals with a platform to disseminate high-quality, peer-reviewed articles that explore the intricacies of viral genetics and their implications in health and disease. With an impact factor placing it in the Q3 quartile across multiple categories in 2023, including Genetics and Virology, VIRUS GENES serves as a crucial resource for academics seeking to stay at the forefront of viral research. Its commitment to showcasing innovative research makes it an invaluable asset for students and professionals aiming to deepen their knowledge in the rapidly evolving landscape of virology. Although currently not offering Open Access, the journal ensures wide accessibility through institutional subscriptions, thereby playing a vital role in the collaboration between scientists globally.

Food and Environmental Virology

Advancing Research at the Intersection of Food and Environmental Virology
Publisher: SPRINGERISSN: 1867-0334Frequency: 4 issues/year

Food and Environmental Virology is a distinguished journal published by SPRINGER, focusing on the intersection of virology, food science, and environmental health. With its ISSN 1867-0334 and E-ISSN 1867-0342, this journal stands out for its contributions to the understanding of viral pathogens affecting food safety and environmental sustainability. Operating from its esteemed location in New York, USA, the journal has made significant strides since its inception in 2009, with a converged publication period extending to 2024. It currently holds a commendable position within various categories, ranking Q3 in Epidemiology and Virology and Q2 in both Food Science and Health, Toxicology and Mutagenesis, indicating its crucial role in informing both research and policy in these fields. With impressive Scopus rankings—such as 82nd out of 389 in Food Science and 38th out of 148 in Epidemiology—Food and Environmental Virology continues to be a vital resource for researchers, professionals, and students committed to advancing knowledge and practices around food safety and public health. While it operates under a subscription model, the rigorous peer-review process ensures that only high-quality research is published, maintaining the journal’s integrity and relevance in the scientific community.

VIROLOGICA SINICA

Exploring the Complexities of Viral Pathogens
Publisher: KEAI PUBLISHING LTDISSN: 1674-0769Frequency: 6 issues/year

VIROLOGICA SINICA, published by KEAI PUBLISHING LTD, is a leading international journal dedicated to the field of virology. With an ISSN of 1674-0769 and E-ISSN of 1995-820X, this esteemed journal showcases cutting-edge research from 2006 to 2024, focusing on critical developments in Immunology, Infectious Diseases, Molecular Medicine, and Virology. As evidenced by its respectable positioning in the Q2 quartile of relevant categories and impressive Scopus rankings—such as Rank #20/80 in Virology—VIROLOGICA SINICA serves as an essential resource for researchers, professionals, and students aiming to deepen their understanding of viral pathogens and their impact on human health. While the journal does not currently offer open access, it remains an invaluable publication for those seeking to stay at the forefront of virology research. Its address is located at 16 Donghuangchenggen North St, Beijing, China, where it continues to foster academic excellence in the rapidly evolving landscape of virology.

Annual Review of Virology

Navigating the complexities of viral pathogenesis and beyond.
Publisher: ANNUAL REVIEWSISSN: 2327-056XFrequency: 1 issue/year

Annual Review of Virology is a premier scholarly journal published by Annual Reviews, dedicated to advancing the field of virology through comprehensive and insightful reviews. Since its inception in 2014, this journal has established itself as a leading resource for researchers, professionals, and students alike, achieving an impressive Q1 ranking in the field of Virology and a Scopus rank of #10 out of 80 in its category, placing it in the 88th percentile. The journal features in-depth analyses of the latest developments in virology, encompassing various aspects such as viral pathogenesis, host interactions, and antiviral strategies, thereby catering to a diverse audience seeking the most relevant and cutting-edge information. Although it is not Open Access, Annual Review of Virology remains an indispensable tool for those engaged in virology research, transforming complex findings into accessible knowledge that shapes future investigations and practical applications in the field.

Journal of Clinical Virology Plus

Fostering collaboration for impactful virology insights.
Publisher: ELSEVIERISSN: 2667-0380Frequency: 4 issues/year

The Journal of Clinical Virology Plus, published by Elsevier, is an essential resource for researchers and professionals in the fields of virology and infectious diseases. Launched in 2021, this journal aims to bridge the gap between clinical research and application, fostering a deeper understanding of viral pathogenesis, diagnostics, and therapeutic strategies. With an ISSN of 2667-0380, this open-access journal brings cutting-edge findings to the global scientific community, facilitating the rapid dissemination of knowledge critical for advancing public health. Positioned in the Q3 category for both Infectious Diseases and Virology in 2023, its ranking reflects its growing influence and relevance in the academic landscape. The journal strives to support innovative research, collaborative studies, and comprehensive reviews that address contemporary challenges in clinical virology. As it converges through the years from 2021 to 2024, Journal of Clinical Virology Plus aims to be a central hub for vital discussions and breakthroughs in this dynamic field.

Journal of Virus Eradication

Uniting scholars to tackle viral challenges.
Publisher: MEDISCRIPT LTDISSN: 2055-6640Frequency: 4 issues/year

Welcome to the Journal of Virus Eradication, a premier publication dedicated to advancing the field of virology and infectious disease research. Published by MEDISCRIPT LTD, this journal provides a vital platform for sharing cutting-edge research findings in key areas including epidemiology, immunology, and public health. With an impressive classification of Q2 in Epidemiology and Infectious Diseases for 2023, this journal exemplifies a commitment to high-quality scholarship and impactful research. The Journal of Virus Eradication is instrumental in disseminating knowledge that tackles viral threats, contributing to global health initiatives aimed at virus containment and eradication. Researchers, professionals, and students alike will find this journal an invaluable resource, making significant contributions to the scientific community and society at large.